Spine

Global Spinal Cord Stimulation Devices Market 2016-2020 with Boston Scientific, Medtronic, Nevro & St. Jude Medical Dominating – Research and Markets

August 11, 2016

DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Global Spinal Cord Stimulation Devices Market 2016-2020” report to their offering.

The global spinal cord stimulation (SCS) devices market to grow at a CAGR of 4.84% during the period 2016-2020.

The report covers the present scenario and the growth prospects of the global spinal cord stimulation (SCS) devices market for 2016-2020. To calculate the market size, we consider the revenue generated from the sale of SCS devices. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Shift of surgeons’ focus toward SCS procedures will be a key trend for market growth. Surgeons prefer MIS compared with open surgery as it is considered to be safe and allows patients to recover faster. They have fewer scars on the operated area and the surgery is not less painful compared with the other surgeries. MIS is usually carried out in outpatient settings and requires only a short hospital stay.

MIS has gained huge acceptance as it reduces the operative traumatic stress without compromising on therapeutic benefits. The latest robotic-assisted technique requires incisions of a few millimeters in length, as well as highly skilled surgeons. The use of MIS techniques to treat spine-related disorders is likely to increase in the coming years.

According to the report, one of the key drivers for market growth will be rapid advances in high-frequency device technologies leading to rise in implantation procedures. Manufacturers are spending heavily on research to increase the efficiency of SCS devices and develop innovative products for improved patient care. The older versions of devices with battery life of 3-5 years are being replaced with the latest rechargeable devices, which have a battery life of 15-20 years.

These new advanced devices can be used in future for indications related to chronic, intractable pain of the trunk and limbs. The upcoming devices are much more refined, upgraded, and tailor-made in contrast to the currently used SCS devices that have procedural invasiveness, weigh more, and are ineffective in pain relief over time.

Key vendors

– Boston Scientific

– Medtronic

– Nevro

– St. Jude Medical

Other prominent vendors

– Greatbatch

– Stimwave

Key Topics Covered:

Part 01: Executive summary

Part 02: Scope of the report

Part 03: Market research methodology

Part 04: Introduction

Part 05: Market landscape

Part 06: Market segmentation by application

Part 07: Market segmentation by product

Part 08: Market segmentation by end-user

Part 09: Geographical segmentation

Part 10: Market drivers

Part 11: Impact of drivers

Part 12: Market challenges

Part 13: Impact of drivers and challenges

Part 14: Market trends

Part 15: Vendor landscape

Part 16: Key vendor analysis

Part 17: Appendix

For more information about this report visit http://www.researchandmarkets.com/research/x35kkc/global_spinal

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Print Friendly, PDF & Email
Tags

Josh Sandberg

Josh Sandberg is the President of Ortho Spine Partners and Partner for The De Angelis Group. He also serves as Co-Founder and Editor of OrthoSpineNews.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button
Close